First Affiliated Hospital Xi'an Jiaotong University

This study looks at whether adding a clot-removal step to the standard heart attack procedure helps prevent future heart problems and protects heart function. About 6,760 adults with a severe type of heart attack and large clots will be randomly assigned to get either the standar…

This study tests whether giving a clot-busting drug (rhPro-UK) before a procedure to remove a large blood clot from the brain can help people who had a stroke 4.5 to 24 hours earlier. About 820 adults with severe stroke symptoms will receive either the drug or a placebo, followed…

This early-phase study tests a new type of immune cell therapy (bispecific AbTCR T-cells) in 3 adults with B-cell lymphoma that has returned or not responded to at least two prior treatments. The therapy targets two proteins (CD19 and CD22) on cancer cells to try to destroy them.…

This study tests whether adding thiotepa to the standard melphalan treatment before a stem cell transplant can lower the chance of cancer returning in people with multiple myeloma. About 204 adults who haven't reached full remission will be randomly assigned to get either the new…